The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy

被引:0
|
作者
Fu, Hongliang [1 ]
Ma, Chao [1 ]
Li, Jianing [1 ]
Feng, Fang [1 ]
Wu, Shuqi [1 ]
Ye, Zhiyi [1 ]
Wang, Hui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Nucl Med, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China
关键词
Thyroid neoplasms; Ablation; Thyroidectomy; RECOMBINANT HUMAN THYROTROPIN; COMPLETION THYROIDECTOMY; RADIOACTIVE IODINE; FOLLOW-UP; CANCER; PAPILLARY; THERAPY; WITHDRAWAL; HORMONE; IMPACT;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BACKGROUND: The aim of this study was to evaluate the efficacy of radioiodine remnant ablation (RRA) for differentiated thyroid carcinoma (DTC) patients with an incomplete thyroidectomy. METHODS: The medical histories of postsurgical DTC patients who accepted RRA between 2010 and 2012 were retrospectively reviewed. Among them, 113 patients who had undergone a total or near-total thyroidectomy comprised the complete thyroidectomy group (CT group) and the remaining 40 patients who had undergone a lobectomy or sub-total thyroidectomy comprised the incomplete thyroidectomy group (ICT group). The difference in the patients' age, gender, histology, serum TSH level and 24hr radioactive iodine uptake (RIU) between the two groups was analyzed by chi(2) Test or ANOVA. The efficacy of RRA in ICT group was evaluated by comparing its rate of complete ablation after the first RRA and its cumulative rate of complete ablation after the second RRA to the rate of complete ablation after the first RRA in CT group respectively by chi(2) Test. RESULTS: Of all the clinical characteristics, only serum TSH level and 24hr RIU have significant difference between two groups (P<0.01 for both). The rate of complete ablation after the first RRA was 67.26% in CT group. The rate of complete ablation after the first RRA and the cumulative rate of complete ablation after the second RRA was 27.50% and 67.50% respectively in ICT group. The ablative rate of the first RRA between the two groups was compared by chi(2) Test and the difference was significant (P<0.01). The ablative rate of the first RRA in CT group was compared with the cumulative rate of the second RRA in ICT group and the difference was not significant (P=0.978). CONCLUSIONS: Although the efficacy of RRA in DTC patients with an incomplete thyroidectomy is not as good as that of patients with a complete thyroidectomy after the first RRA, a higher ablative rate can still be achieved after the second or third RRA.
引用
收藏
页码:280 / 284
页数:5
相关论文
共 50 条
  • [1] Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma
    Frederik A. Verburg
    Markus Dietlein
    Michael Lassmann
    Markus Luster
    Christoph Reiners
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [2] Editorial: Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation
    Haugen, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3665 - 3667
  • [3] Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma
    Verburg, Frederik A.
    Dietlein, Markus
    Lassmann, Michael
    Luster, Markus
    Reiners, Christoph
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (03) : 343 - 346
  • [4] Analysis of Critical Parameters for Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Carcinoma
    Mika, A. Valkovic
    Nekic, J.
    Ivankovic, S. Grbac
    Valkovic, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S482 - S482
  • [5] Effectiveness of Reduced Radioiodine Activity for Thyroid Remnant Ablation after Total Thyroidectomy in Patients with Low to Intermediate Risk Differentiated Thyroid Carcinoma
    Todica, Andrei
    Haidvogl, Sabine
    Fendler, Wolfgang Peter
    Ilhan, Harun
    Rominger, Axel
    Haug, Alexander Robert
    Bartenstein, Peter
    Lehner, Sebastian
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2017, 56 (06): : 211 - 218
  • [6] Low dose radioiodine activity for ablation after thyroidectomy in patients with differentiated thyroid carcinoma
    Henao Celada, Y. K.
    Gomez Fernandez, I.
    Duran Barquero, C.
    Ardila Manjarres, J.
    Ardila Mantilla, J.
    Lozano Murgas, L.
    Zamudio, D.
    Rotger Regi, A.
    Alonso Farto, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S610 - S611
  • [7] Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: A randomized clinical trial in 509 patients
    Bal, CS
    Kumar, A
    Pant, GS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04): : 1666 - 1673
  • [8] Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma
    Hay, Ian D.
    McDougall, I. Ross
    Sisson, James C.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (08): : 1395 - 1397
  • [9] Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer
    Bal, CS
    Kumar, A
    Pant, GS
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (02) : 203 - 208
  • [10] Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
    Long, Bin
    Li, Linfa
    Yao, Lifang
    Chen, Shoucong
    Yi, Heqing
    Ye, Xuemei
    Xu, Dong
    Wu, Peng
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (08) : 244 - 247